Search | TVST | ARVO Journals

Showing 1 – 20 of 110

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

OTII OVA-specific Tregs can be Induced to Traffic into the Mouse Eye and Modulate Experimental Autoimmune Uveoretinitis via Intravitreal Injection of Ovalbumin Peptide.

Alan Roy Abraham; Panayiotis Maghsoudlou; Suci Cendanawati; Alison J Clare; David Alexander Copland; Lindsay B Nicholson; Andrew D Dick

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2993.

ARVO Annual Meeting Abstract June 2024

Modelling RPE65 and RPGR retinal gene therapy in non-human primates: (I) RPE changes following subretinal viral vector administration

Kanmin Xue; Celia Sourd; Molly John; Cristina Martinez-Fernandez Dela Camara; Ahmed Salman; Joel Quinn; Monica L Hu; Hoda Shamsnajafabadi; Andrew D Dick; Robert E MacLaren; Jasmina Cehajic Kapetanovic

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5078.

Multidisciplinary Ophthalmic Imaging January 2024

Establishing the Normative Data Set Necessary for Imaging-Based Childhood Uveitis Surveillance: A Cross-Sectional Study

PDF

Ameenat Lola Solebo; Alice Bellchambers; Salomey Kellett; Jugnoo S. Rahi; Andrew D. Dick
TAGS: child, datasets, diagnostic imaging, surveillance, medical, uveitis, eye
Invest. Ophthalmol. Vis. Sci.. 2024; 65(1):9. https://doi.org/10.1167/iovs.65.1.9

ARVO Annual Meeting Abstract June 2023

Delivering topical IL-33 mRNA + nanoparticles to treat neovascular age-related macular degeneration.

Lisa J Hill; Chloe Thomas; Alison Clare; Lynn Jena; Chris Weston; Eleanor Hickman; Jamie Cowley; Alastair K Denniston; Andrew D Dick; Dave A Copland; Helen O McCarthy

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):930.

ARVO Annual Meeting Abstract June 2023

Impact of differential sex response to the vector when developing IL-33 gene therapy for AMD

Alison J Clare; Dave A Copland; Filip Langer; Amy Ward; Ying Kai Chan; Andrew D Dick

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):767.

ARVO Annual Meeting Abstract June 2023

IL-23 drives uveitis by acting on a novel population of resident ocular T cells

David Copland; Robert Hedley; Amy Ward; Colin Chu; Jonathan Sherlock; Andrew D Dick

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2864.

ARVO Annual Meeting Abstract June 2023

Anterior Segment Optical Coherence Tomography Detects Cells in Children without Eye Disease

Ameenat Lola Solebo; Salomey Kellett; Alex Fraser; Alice Bellchambers; Enda McGonigle; Ajeeta Patel; Andrew D Dick; Jugnoo Rahi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1434.

ARVO Annual Meeting Abstract June 2023

Quality assessment of anterior segment OCT images: development and validation of quality criteria

Radhika Pooja Patel; Harry Petrushkin; Katie Etherton; Katherine Terence; Karim Nizam; Andrew D Dick; Jugnoo Rahi; Ameenat Lola Solebo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3397.

ARVO Annual Meeting Abstract June 2023

Manipulating autophagy activity through small molecules to protect against RPE degeneration

Katherine Lenna Cox; Jenna Le Brun Powell; Harley Buck; Andrew D Dick; Jian Liu

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3880.

ARVO Annual Meeting Abstract June 2023

Intravitreal AAV delivery causes long-term subclinical microglia activation in mice

Philip Michael Langer; Amy Ward; Oliver Hugh Bell; Alison J Clare; Colin Chu; Ying Kai Chan; Andrew Dick; David Copland

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):781.

ARVO Annual Meeting Abstract June 2023

Pathways to detection of non-infectious childhood uveitis in the UK: Findings from the UNICORN cohort study

Salomey Kellett; Harry Petrushkin; Jane Ashworth; Alan Connor; Eibhlin McLoone; Conrad Schmoll; Srilakshmi Sharma; Eleftherios Agorogiannis; Jerald Williams; Jessy Choi; Anas Injarie; Narman Puvanachandra; Patrick Watts; Andrew Dick; Jugnoo Rahi; Ameenat Lola Solebo

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1421.

ARVO Annual Meeting Abstract June 2022

A phase 2 randomized controlled trial of the Janus Kinase (JAK) inhibitor filgotinib in patients with noninfectious uveitis

Sunil K Srivastava; Tim Watkins; Quan Dong Nguyen; Sumit Sharma; David Scales; Mark Dacey; Rajiv E Shah; David Chu; Dilraj S Grewal; Lisa Faia; Eric B Suhler; Mark Genovese; Ying Guo; William Barchuk; Andrew D Dick; James T Rosenbaum

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2678.

ARVO Annual Meeting Abstract June 2022

Perceptions and experiences of health care service use during the pandemic for children with uveitis: UNICORNS-C19 study

Ameenat Lola Solebo; Salomey Kellett; Jugnoo Rahi; Andrew D Dick; Rachel Knowles; Valerija Tadic

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4468 – A0178.

ARVO Annual Meeting Abstract June 2022

Peptide-based immunotherapy against oxidized elastin ameliorates pathology in mouse model of smoke-induced ocular injury

Baerbel Rohrer; Nathaniel Parsons; Balasubramaniam Annamalai; Crystal Nicholson; Elisabeth Obert; Bryan W. Jones; Andrew D Dick

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4600 – F0392.

ARVO Annual Meeting Abstract June 2021

Delivering topical IL-33 with a cell penetrating peptide to treat neovascular age-related macular degeneration.

Chloe Naomi Thomas; Sofia Theodoropoulou; Christopher Weston; Jessica Cooklin; Dave Copland; Andrew D Dick; Alastair K Denniston; Lisa J Hill

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):212.

Review April 2021

Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020

PDF

Ying Kai Chan; Andrew D. Dick; Sara Mary Hall; Thomas Langmann; Curtis L. Scribner; Brian C. Mansfield; for the Ocular Gene Therapy Inflammation Working Group
TAGS: blindness, gene therapy, inflammation, spatial vectors, disease vectors
Trans. Vis. Sci. Tech.. 2021; 10(4):3. https://doi.org/10.1167/tvst.10.4.3

Clinical and Epidemiologic Research May 2020

Ambient Air Pollution Associations with Retinal Morphology in the UK Biobank

PDF

Sharon Y. L. Chua; Anthony P. Khawaja; Andrew D. Dick; James Morgan; Baljean Dhillon; Andrew J. Lotery; Nicholas G. Strouthidis; Charles Reisman; Tunde Peto; Peng T. Khaw; Paul J. Foster; Praveen J. Patel; on behalf of The UK Biobank Eye and Vision Consortium
TAGS: air pollution, biobanks, language morphology, morphology
Invest. Ophthalmol. Vis. Sci.. 2020; 61(5):32. https://doi.org/10.1167/iovs.61.5.32

Glaucoma November 2019

The Relationship Between Ambient Atmospheric Fine Particulate Matter (PM 2.5 ) and Glaucoma in a Large Community Cohort

PDF

Sharon Y. L. Chua; Anthony P. Khawaja; James Morgan; Nicholas Strouthidis; Charles Reisman; Andrew D. Dick; Peng T. Khaw; Praveen J. Patel; Paul J. Foster; for the UK Biobank Eye and Vision Consortium
TAGS: cohort studies, glaucoma, particulate matter, community, intraocular pressure, self-report, air pollution
Invest. Ophthalmol. Vis. Sci.. 2019; 60(14):4915-4923. https://doi.org/10.1167/iovs.19-28346

Articles October 2019

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro

PDF

Marina Mesquida; Faye Drawnel; Philippa J. Lait; David A. Copland; Madeleine L. Stimpson; Victor Llorenç; Maite Sainz de la Maza; Alfredo Adan; Gabriella Widmer; Pamela Strassburger; Sascha Fauser; Andrew D. Dick; Richard W. J. Lee; Blanca Molins
TAGS: interleukin 6 receptor, interleukin-6, macular edema, personal integrity, blood-retinal barrier
Trans. Vis. Sci. Tech.. 2019; 8(5):32. https://doi.org/10.1167/tvst.8.5.32

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Interleukin-33 attenuates ocular angiogenesis through a mast cell dependent pathway.

Sofia Theodoropoulou; David Copland; Kepeng Ou; Jian Liu; Neal Millar; Andrew D Dick

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):987.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

OTII OVA-specific Tregs can be Induced to Traffic into the Mouse Eye and Modulate Experimental Autoimmune Uveoretinitis via Intravitreal Injection of Ovalbumin Peptide.

Modelling RPE65 and RPGR retinal gene therapy in non-human primates: (I) RPE changes following subretinal viral vector administration

Establishing the Normative Data Set Necessary for Imaging-Based Childhood Uveitis Surveillance: A Cross-Sectional Study

Delivering topical IL-33 mRNA + nanoparticles to treat neovascular age-related macular degeneration.

Impact of differential sex response to the vector when developing IL-33 gene therapy for AMD

IL-23 drives uveitis by acting on a novel population of resident ocular T cells

Anterior Segment Optical Coherence Tomography Detects Cells in Children without Eye Disease

Quality assessment of anterior segment OCT images: development and validation of quality criteria

Manipulating autophagy activity through small molecules to protect against RPE degeneration

Intravitreal AAV delivery causes long-term subclinical microglia activation in mice

Pathways to detection of non-infectious childhood uveitis in the UK: Findings from the UNICORN cohort study

A phase 2 randomized controlled trial of the Janus Kinase (JAK) inhibitor filgotinib in patients with noninfectious uveitis

Perceptions and experiences of health care service use during the pandemic for children with uveitis: UNICORNS-C19 study

Peptide-based immunotherapy against oxidized elastin ameliorates pathology in mouse model of smoke-induced ocular injury

Delivering topical IL-33 with a cell penetrating peptide to treat neovascular age-related macular degeneration.

Inflammation in Viral Vector-Mediated Ocular Gene Therapy: A Review and Report From a Workshop Hosted by the Foundation Fighting Blindness, 9/2020

Ambient Air Pollution Associations with Retinal Morphology in the UK Biobank

The Relationship Between Ambient Atmospheric Fine Particulate Matter (PM 2.5 ) and Glaucoma in a Large Community Cohort

Modelling Macular Edema: The Effect of IL-6 and IL-6R Blockade on Human Blood–Retinal Barrier Integrity In Vitro

Interleukin-33 attenuates ocular angiogenesis through a mast cell dependent pathway.

To View More...

You must be signed into an individual account to use this feature.